Dr. Pavle Repovic, MD, PhD

Dr. Repovic practices at Swedish Medical Center -First Hill in Seattle, Washington.

Dr. Repovic's NPI, 1649437211, was assigned on May 20, 2008. Dr. Repovic graduated from University of Alabama School of Medicine in 2004. Dr. Repovic holds Washington license MD 60166620.

Dr. Repovic's primary practice is Swedish Medical Center -First Hill, at 747 Broadway, Seattle, WA 98122 in King County. The practice phone is (206) 386-6000.

Dr. Repovic's primary practice is Swedish Medical Center -First Hill in Seattle, Washington. Dr. Repovic is also affiliated with Swedish First Hill Campus. The medical group on file is Swedish Health Services. Dmand AI also links Dr. Repovic to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Repovic practices, 6 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Repovic's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dmand AI has Dr. Repovic's licenses on file in 2 states: Washington and New York.

CMS data shows 235 Medicare services from Dr. Repovic across 4 procedure codes in 2024, for 86 Medicare patients. Medicare paid $16,256 for them. Every service was in an office.

CMS counts 86 Medicare patients who saw Dr. Repovic in 2024. The largest group is 65 to 74, with 37 patients. 55% of them have high cholesterol, and 37% have high blood pressure. 15% are also on Medicaid. Their average risk score is 1.40, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Repovic's median patient age at 60, with 69% women.

In 2024, Dr. Repovic wrote 1,531 Medicare Part D claims for 156 patients. 92% of them were for generic drugs. CMS names the drug for 1,343 of them, across 35 drugs with 11 or more claims each, at $765,976 in total drug cost. In 2023, CMS named 1,432 claims across 38 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Repovic for performance year 2024, reported as part of a group. Dr. Repovic accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Repovic as offering telehealth.

Dmand AI links 40 papers to Dr. Repovic, published from 2014 to 2025. 2021 was the busiest year, with 8. The most frequent topics are Multiple Sclerosis, Multiple Sclerosis, Chronic Progressive and Multiple Sclerosis, Relapsing-Remitting. Dr. Repovic has published most often in Mult Scler. Dr. Repovic's most frequent co-authors are James Bowen, MD, MPH, Annette Wundes, MD and Stanley L. Cohan, MD.

Dmand AI links Dr. Repovic to 2 clinical trials. Conditions studied include Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting and Demyelinating Autoimmune Diseases, CNS.

CMS Open Payments shows 1,919 general payments to Dr. Repovic from 18 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 62% of the total. Biogen, Inc. paid the most, $388,983. It also lists 19 research payments totaling $22,300 from 2016 to 2025.

Dr. Repovic graduated from University of Alabama School of Medicine in 2004.